Article
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms- Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience.
Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) - 1 Dec 2023
Popova-Labachevska Marija, Cvetanoski Milche, Ridova Nevenka, Trajkova Sanja, Stojanovska-Jakimovska Simona, Mojsovska Tara, Stojanoski Zlate, Pivkova-Veljanovska Aleksandra, Panovska-Stavridis Irina
Abstract excerpt
Background: Treatment of Philadelphia chromosome negative myeloproliferative neoplasms (Ph - MPNs) requires individualized approach depending on multiple factors. Novel pegylated Interferon (IFN) formulations have become an attractive therapeutic option in young Ph- MPN patients associated with better patient compliance. Methods: In this retrospective observational study a total of 16 high-risk Ph- MPN patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.